HB 2181

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

In committee Last action January 30, 2026: Referred to Health

Official bill page and text: palegis.us

Sponsors 12

Prime sponsor: Chris Pielli
Cosponsors (11): Benjamin Sanchez, Brian Munroe, Carol Hill-Evans, Dan Williams, G. Roni Green, Jeanne Mcneill, Jennifer O'Mara, Johanny Cepeda-Freytiz, Lisa Borowski, Liz Hanbidge, Mary Jo Daley

Status

In committee as of January 30, 2026. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
January 30, 2026	House	Referred to Health

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.